KR1 PLC (LON:KR1) said it has appointed Mona Elisa, a former star-trader at Goldman Sachs, as a non-executive director of the company.
In an announcement after the close on Wednesday, the digital asset investment firm said Elisa has been granted options to subscribe for 77,519 shares in the group at a price of 193.5p each, exercisable only in the event that certain future milestones are achieved.
READ: KR1 invests US$200,000 into personal data network pioneer Starks
Elisa is currently the chief executive of Avantgarde Finance and was formerly the co-founder and CEO of Melonport AG which developed Enzyme (formerly Melon), an Ethereum-based protocol for decentralised on-chain asset management.
“I am honoured and delighted to be joining the board. The KR1 team are pioneers in the crypto investment space and first discovered Enzyme (then, Melon) in 2016 before we were even looking to raise capital. KR1 offers much more than capital, they understand the challenges an entrepreneur faces and have been around long enough to prove that they are there for their portfolio companies during the ups and the downs. This unique combination of skills and experience sets them up as the best kind of investor and mentor a founder could ask for,” Elisa said in a statement.
“We are thrilled to appoint Mona. Enzyme (formerly Melon) was the company’s first major investment and, since then, we have shared an incredibly successful journey together. Having been a star in traditional finance early in her career, Mona brings a lot of experience and an extensive network in the blockchain world to the table. Her energy and experience will be highly welcome and appreciated going forward,” added KR1 managing director and co-founder Keld van Schreven.
Shares in KR1 were trading at around 206p in early deals on the Aquis Exchange on Thursday.